GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Episurf Medical AB (OSTO:EPIS B) » Definitions » Cyclically Adjusted PS Ratio

Episurf Medical AB (OSTO:EPIS B) Cyclically Adjusted PS Ratio : 0.98 (As of Jul. 08, 2025)


View and export this data going back to 2010. Start your Free Trial

What is Episurf Medical AB Cyclically Adjusted PS Ratio?

As of today (2025-07-08), Episurf Medical AB's current share price is kr0.0586. Episurf Medical AB's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 was kr0.06. Episurf Medical AB's Cyclically Adjusted PS Ratio for today is 0.98.

The historical rank and industry rank for Episurf Medical AB's Cyclically Adjusted PS Ratio or its related term are showing as below:

OSTO:EPIS B' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.9   Med: 20.44   Max: 71.51
Current: 0.96

During the past years, Episurf Medical AB's highest Cyclically Adjusted PS Ratio was 71.51. The lowest was 0.90. And the median was 20.44.

OSTO:EPIS B's Cyclically Adjusted PS Ratio is ranked better than
72.05% of 483 companies
in the Medical Devices & Instruments industry
Industry Median: 2.24 vs OSTO:EPIS B: 0.96

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Episurf Medical AB's adjusted revenue per share data for the three months ended in Mar. 2025 was kr0.006. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is kr0.06 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Episurf Medical AB Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Episurf Medical AB's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Episurf Medical AB Cyclically Adjusted PS Ratio Chart

Episurf Medical AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 43.36 67.58 33.45 13.80 2.37

Episurf Medical AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.10 3.79 2.62 2.37 2.33

Competitive Comparison of Episurf Medical AB's Cyclically Adjusted PS Ratio

For the Medical Devices subindustry, Episurf Medical AB's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Episurf Medical AB's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Episurf Medical AB's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Episurf Medical AB's Cyclically Adjusted PS Ratio falls into.


;
;

Episurf Medical AB Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Episurf Medical AB's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=0.0586/0.06
=0.98

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Episurf Medical AB's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Episurf Medical AB's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=0.006/132.8245*132.8245
=0.006

Current CPI (Mar. 2025) = 132.8245.

Episurf Medical AB Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201506 0.015 99.995 0.020
201509 0.006 100.228 0.008
201512 0.011 100.276 0.015
201603 0.015 100.751 0.020
201606 0.018 101.019 0.024
201609 0.016 101.138 0.021
201612 0.032 102.022 0.042
201703 0.015 102.022 0.020
201706 0.012 102.752 0.016
201709 0.010 103.279 0.013
201712 0.018 103.793 0.023
201803 0.022 103.962 0.028
201806 0.017 104.875 0.022
201809 0.025 105.679 0.031
201812 0.027 105.912 0.034
201903 0.026 105.886 0.033
201906 0.019 106.742 0.024
201909 0.009 107.214 0.011
201912 0.011 107.766 0.014
202003 0.012 106.563 0.015
202006 0.003 107.498 0.004
202009 0.006 107.635 0.007
202012 0.006 108.296 0.007
202103 0.006 108.360 0.007
202106 0.007 108.928 0.009
202109 0.005 110.338 0.006
202112 0.004 112.486 0.005
202203 0.005 114.825 0.006
202206 0.005 118.384 0.006
202209 0.004 122.296 0.004
202212 0.005 126.365 0.005
202303 0.007 127.042 0.007
202306 0.007 129.407 0.007
202309 0.008 130.224 0.008
202312 0.010 131.912 0.010
202403 0.010 132.205 0.010
202406 0.009 132.716 0.009
202409 0.005 132.304 0.005
202412 0.005 132.987 0.005
202503 0.006 132.825 0.006

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Episurf Medical AB  (OSTO:EPIS B) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Episurf Medical AB Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Episurf Medical AB's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Episurf Medical AB Business Description

Traded in Other Exchanges
Address
Karlavagen 60, Stockholm, SWE, 114 49
Episurf Medical AB is a medical device company. The company develops, manufactures, and commercializes solutions for the repair of the local cartilage damage in human joints. Its first patient-specific product portfolio, the knee portfolio, consists of the existing products Episealer Condyle Solo and Episealer Trochlea Solo, Episealer Femoral Twin, Epiguide MOS, and Epioscopy. Episealer Patellofemoral System for the treatment of osteoarthritis limited to thepatellofemoral part of the knee joint.

Episurf Medical AB Headlines

No Headlines